Literature DB >> 18553057

Identification of chemical inhibitors of protein-kinase CK2 subunit interaction.

Béatrice Laudet1, Virginie Moucadel, Renaud Prudent, Odile Filhol, Yung-Sing Wong, Daniel Royer, Claude Cochet.   

Abstract

Protein kinase CK2 is a multi-subunit complex whose dynamic assembly appears as a crucial point of regulation. The ability to interfere with specific protein-protein interactions has already provided powerful means of influencing the functions of selected proteins within the cell. CK2beta-derived cyclopeptides that target a well-defined hydrophobic pocket on CK2alpha have been previously characterized as potent inhibitors of CK2 subunit assembly [9]. As a first step toward the rational design of low molecular weight CK2 antagonists, we have in the present study screened a collection of podophyllotoxine indolo-analogues to identify chemical inhibitors of the CK2 subunit interaction. We report the identification of a podophyllotoxine indolo-analogue as a chemical ligand that binds to the CK2alpha/CK2beta interface inducing selective disruption of the CK2alpha/CK2beta assembly and concomitant inhibition of CK2alpha activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553057     DOI: 10.1007/s11010-008-9821-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha.

Authors:  J K Hériché; F Lebrin; T Rabilloud; D Leroy; E M Chambaz; Y Goldberg
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

2.  Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits.

Authors:  Odile Filhol; Arsenio Nueda; Véronique Martel; Delphine Gerber-Scokaert; Maria José Benitez; Catherine Souchier; Yasmina Saoudi; Claude Cochet
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  Protein kinase CK2: a new view of an old molecular complex.

Authors:  Odile Filhol; Jean-Louis Martiel; Claude Cochet
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 5.  Protein-protein interactions as targets for small molecule drug discovery.

Authors:  David C Fry
Journal:  Biopolymers       Date:  2006       Impact factor: 2.505

Review 6.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 7.  Promiscuous subunit interactions: a possible mechanism for the regulation of protein kinase CK2.

Authors:  C C Allende; J E Allende
Journal:  J Cell Biochem Suppl       Date:  1998

8.  Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria.

Authors:  N Grankowski; B Boldyreff; O G Issinger
Journal:  Eur J Biochem       Date:  1991-05-23

9.  Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Authors:  Béatrice Laudet; Caroline Barette; Vincent Dulery; Olivier Renaudet; Pascal Dumy; Alexandra Metz; Renaud Prudent; Alexandre Deshiere; Otto Dideberg; Odile Filhol; Claude Cochet
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

Review 10.  Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives.

Authors:  M Gordaliza; P A García; J M Miguel del Corral; M A Castro; M A Gómez-Zurita
Journal:  Toxicon       Date:  2004-09-15       Impact factor: 3.033

View more
  21 in total

1.  Identification of novel CK2 inhibitors with a benzofuran scaffold by novel non-radiometric in vitro assays.

Authors:  Andreas Gratz; Uwe Kuckländer; Ricardo Bollig; Claudia Götz; Joachim Jose
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

2.  Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence.

Authors:  Daniel Lim; Daniel A Gold; Lindsay Julien; Emily E Rosowski; Wendy Niedelman; Michael B Yaffe; Jeroen P J Saeij
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

3.  Inhibition of protein-protein interactions with low molecular weight compounds.

Authors:  Marilyn M Matthews; David J Weber; Paul S Shapiro; Andrew Coop; Alexander D Mackerell
Journal:  Curr Trends Med Chem       Date:  2008-01-01

4.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

5.  Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

Authors:  Aurélie Gouron; Anne Milet; Helene Jamet
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

6.  Copper-catalyzed multicomponent reactions for the efficient synthesis of diverse spirotetrahydrocarbazoles.

Authors:  Shao-Cong Zhan; Ren-Jie Fang; Jing Sun; Chao-Guo Yan
Journal:  Beilstein J Org Chem       Date:  2022-07-07       Impact factor: 2.544

7.  Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.

Authors:  Mario A Pagano; Oriano Marin; Giorgio Cozza; Stefania Sarno; Flavio Meggio; Kate J Treharne; Anil Mehta; Lorenzo A Pinna
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

8.  Mass Spectrometry Reveals Protein Kinase CK2 High-Order Oligomerization via the Circular and Linear Assembly.

Authors:  Wei-Guang Seetoh; Daniel Shiu-Hin Chan; Dijana Matak-Vinković; Chris Abell
Journal:  ACS Chem Biol       Date:  2016-03-29       Impact factor: 5.100

9.  IP-FCM measures physiologic protein-protein interactions modulated by signal transduction and small-molecule drug inhibition.

Authors:  Stephen E P Smith; Anya T Bida; Tessa R Davis; Hugues Sicotte; Steven E Patterson; Diana Gil; Adam G Schrum
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  Antitumoral activity of allosteric inhibitors of protein kinase CK2.

Authors:  Virginie Moucadel; Renaud Prudent; Céline F Sautel; Florence Teillet; Caroline Barette; Laurence Lafanechere; Veronique Receveur-Brechot; Claude Cochet
Journal:  Oncotarget       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.